Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21212 | 368 | 33.6 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
330 | 17366 | FABRY DISEASE//GAUCHER DISEASE//MUCOPOLYSACCHARIDOSES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DANON DISEASE | Author keyword | 79 | 87% | 11% | 39 |
2 | LAMP 2 DEFICIENCY | Author keyword | 11 | 100% | 2% | 6 |
3 | LAMP 2 | Author keyword | 9 | 41% | 5% | 17 |
4 | LAMP2 | Author keyword | 8 | 48% | 3% | 12 |
5 | AUTOPHAGIC VACUOLAR MYOPATHY | Author keyword | 6 | 80% | 1% | 4 |
6 | X LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY | Author keyword | 6 | 80% | 1% | 4 |
7 | X LINKED MYOPATHY | Author keyword | 4 | 67% | 1% | 4 |
8 | LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2 | Author keyword | 4 | 75% | 1% | 3 |
9 | LAMP2 DEFICIENCY | Author keyword | 3 | 100% | 1% | 3 |
10 | VMA21 | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DANON DISEASE | 79 | 87% | 11% | 39 | Search DANON+DISEASE | Search DANON+DISEASE |
2 | LAMP 2 DEFICIENCY | 11 | 100% | 2% | 6 | Search LAMP+2+DEFICIENCY | Search LAMP+2+DEFICIENCY |
3 | LAMP 2 | 9 | 41% | 5% | 17 | Search LAMP+2 | Search LAMP+2 |
4 | LAMP2 | 8 | 48% | 3% | 12 | Search LAMP2 | Search LAMP2 |
5 | AUTOPHAGIC VACUOLAR MYOPATHY | 6 | 80% | 1% | 4 | Search AUTOPHAGIC+VACUOLAR+MYOPATHY | Search AUTOPHAGIC+VACUOLAR+MYOPATHY |
6 | X LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY | 6 | 80% | 1% | 4 | Search X+LINKED+MYOPATHY+WITH+EXCESSIVE+AUTOPHAGY | Search X+LINKED+MYOPATHY+WITH+EXCESSIVE+AUTOPHAGY |
7 | X LINKED MYOPATHY | 4 | 67% | 1% | 4 | Search X+LINKED+MYOPATHY | Search X+LINKED+MYOPATHY |
8 | LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2 | 4 | 75% | 1% | 3 | Search LYSOSOME+ASSOCIATED+MEMBRANE+PROTEIN+2 | Search LYSOSOME+ASSOCIATED+MEMBRANE+PROTEIN+2 |
9 | LAMP2 DEFICIENCY | 3 | 100% | 1% | 3 | Search LAMP2+DEFICIENCY | Search LAMP2+DEFICIENCY |
10 | VMA21 | 3 | 100% | 1% | 3 | Search VMA21 | Search VMA21 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LINKED VACUOLAR CARDIOMYOPATHY | 38 | 86% | 5% | 19 |
2 | NORMAL ACID MALTASE | 26 | 68% | 6% | 23 |
3 | LYSOSOMAL GLYCOGEN STORAGE | 23 | 76% | 4% | 16 |
4 | LAMP 2 GENE MUTATION | 21 | 90% | 2% | 9 |
5 | EXON ORGANIZATION | 17 | 100% | 2% | 8 |
6 | DANON DISEASE | 11 | 40% | 6% | 22 |
7 | EXCESSIVE AUTOPHAGY | 11 | 78% | 2% | 7 |
8 | KDA SIALOGLYCOPROTEIN | 6 | 100% | 1% | 4 |
9 | VACUOLATED MYOPATHY | 6 | 100% | 1% | 4 |
10 | LAMP 2 | 4 | 47% | 2% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Danon disease: a phenotypic expression of LAMP-2 deficiency | 2015 | 2 | 29 | 72% |
Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle | 2008 | 58 | 36 | 50% |
Danon disease: focusing on heart | 2012 | 9 | 29 | 100% |
Disease model: LAMP-2 enlightens Danon disease | 2001 | 60 | 7 | 86% |
LYSOSOMAL MEMBRANE-GLYCOPROTEINS - STRUCTURE, BIOSYNTHESIS, AND INTRACELLULAR TRAFFICKING | 1991 | 385 | 63 | 48% |
Intracellular trafficking of lysosomal membrane proteins | 1996 | 199 | 79 | 56% |
At the acidic edge: emerging functions for lysosomal membrane proteins | 2003 | 294 | 71 | 27% |
Shedding new light on vasculitis: how the LAMP story unfolded | 2012 | 0 | 63 | 59% |
X-linked myopathy with excessive autophagy: a failure of self-eating | 2015 | 0 | 35 | 51% |
Endolysosomal proteolysis and its regulation | 2002 | 159 | 119 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACEUT CELL BIOL | 3 | 23% | 2.7% | 10 |
2 | ADULT MED GENET CLIN | 1 | 50% | 0.3% | 1 |
3 | ANZHEN HOSP BEIJING | 1 | 50% | 0.3% | 1 |
4 | CLIN OPHTHALMOGENET | 1 | 50% | 0.3% | 1 |
5 | CU CARDIOVASC | 1 | 50% | 0.3% | 1 |
6 | CUMMINGS VET | 1 | 50% | 0.3% | 1 |
7 | DIAGNOST ANGIOG INTERVENT RADIOL | 1 | 50% | 0.3% | 1 |
8 | FEDERAT GENET CYTOGENET | 1 | 50% | 0.3% | 1 |
9 | GENET METAB DIS PROGRAM | 1 | 50% | 0.3% | 1 |
10 | MIYAZAKI HIGASHI HOSP | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183637 | I CELL DISEASE//MANNOSE 6 PHOSPHATE//MUCOLIPIDOSIS TYPE III |
2 | 0.0000116561 | ANTILIPOLYTIC DRUGS//CELLULAR AUTOPHAGY//CHAPERONE MEDIATED AUTOPHAGY |
3 | 0.0000102010 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II//ACID ALPHA GLUCOSIDASE |
4 | 0.0000101929 | ASIALOGLYCOPROTEIN RECEPTOR//LIVER TARGETING OF DRUGS//LACTOSAMINATED POLY L LYSINE |
5 | 0.0000096567 | QILIQIANGXIN//DESMIN RELATED CARDIOMYOPATHY//PROT QUAL CONTROL DE AT |
6 | 0.0000083088 | MUCOLIPIDOSIS TYPE IV//MUCOLIPIN//MUCOLIPIDOSIS IV |
7 | 0.0000081756 | LAPTM4B//LAPTM4B 35//LYSOSOMAL PROTEIN TRANSMEMBRANE 4 BETA |
8 | 0.0000076924 | N ACETYLGLUCOSAMINYLTRANSFERASE V//GNT V//GNT III |
9 | 0.0000072529 | HERMANSKY PUDLAK SYNDROME//CHEDIAK HIGASHI SYNDROME//LYST |
10 | 0.0000069104 | MARGARET DYSON VIS//APICAL SORTING//BASOLATERAL SORTING |